OR WAIT null SECS
March 29, 2016
Industry is joining with academia and global health leaders to examine new approaches to biotech manufacturing.
March 11, 2016
Doctors and oncologists agree with pharma companies in opposing the latest proposal from the CMS to revise how it pays for drugs administered in doctors’ offices.
March 07, 2016
And so tax benefits doth make Irishmen of us all…
February 11, 2016
Vaccine R&D has grown exponentially in recent years, spurred by ethical and medical needs to combat lethal infectious outbreaks and increased funding from public and private agencies and organizations.
February 10, 2016
There was scant praise from the medical community for the eighth and final budget plan from the Obama administration.
February 04, 2016
In a hearing held on Feb. 4, 2016, executives from Valeant and Turing had a hard time explaining their rationales for exorbitant price hikes of older drugs.
February 01, 2016
Can the feds negotiate Medicare Part D prices?
January 29, 2016
FDA and industry seek a more consistent, flexible CMC review process for breakthrough therapies.
January 04, 2016
More “me-betters” and more focused breakthroughs could enhance new drug development.
December 28, 2015
The FDA program that encourages biopharma companies to develop new treatments for rare and neglected diseases has been in the spotlight recently.